As of September 30, 2026, Great Tree Pharmacy Co., Ltd. carries a market capitalization of 10.24B, placing it among publicly traded companies globally. Its enterprise value stands at 15.90B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.24B |
| Enterprise Value | 15.90B |
Great Tree Pharmacy Co., Ltd.'s next confirmed earnings release is scheduled for March 4, 2027.
| Earnings Date | 3/4/2027 |
As of September 30, 2026, Great Tree Pharmacy Co., Ltd. has 159.05M shares outstanding.
| Shares Outstanding | 159.05M |
As of September 30, 2026, Great Tree Pharmacy Co., Ltd. trades at a trailing price-to-earnings ratio of 21.07. The price-to-sales ratio is 0.53, and the price-to-book ratio stands at 2.70.
| PE Ratio | 21.07 |
| PS Ratio | 0.53 |
| PB Ratio | 2.70 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | -37.58 |
| P/OCF Ratio | 11.48 |
As of September 30, 2026, Great Tree Pharmacy Co., Ltd. trades at an EV/EBITDA multiple of 11.41 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.82 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 31.71 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 15.90B versus a market cap of 10.24B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 0.82 |
| EV / EBITDA | 11.41 |
| EV / EBIT | 31.71 |
As of September 30, 2026, Great Tree Pharmacy Co., Ltd. maintains a current ratio of 1.36, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 209.97, indicating elevated leverage, while an interest coverage ratio of 14.89 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.36 |
| Quick Ratio | 0.42 |
| Debt / Equity | 209.97 |
| Debt / EBITDA | 5.81 |
| Interest Coverage | 14.89 |
Over the twelve months ended September 30, 2026, Great Tree Pharmacy Co., Ltd. posted a return on equity (ROE) of 12.93, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 3.53 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.44, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.18, useful for judging operating efficiency across full business cycles. The company generates approximately 16.18M in revenue per employee across its workforce of 1,193.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.67 indicates how many times Great Tree Pharmacy Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 12.93 |
| Return on Assets (ROA) | 3.44 |
| Return on Invested Capital (ROIC) | 3.53 |
| Return on Capital Employed (ROCE) | 5.18 |
| Revenue Per Employee | 16.18M |
| Employee Count | 1,193.00 |
| Inventory Turnover | 3.67 |
Over the twelve months ended September 30, 2026, Great Tree Pharmacy Co., Ltd. recorded 111.08M in income tax expense. That works out to an effective tax rate of 19.61, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 566.37M, leaving 484.84M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 111.08M |
| Effective Tax Rate | 19.61 |
As of the close on November 17, 2026, Great Tree Pharmacy Co., Ltd.'s stock has declined approximately 40.48% over the past 52 weeks. The 50-day moving average sits at 64.07, while the 200-day moving average is 72.29.
| 52-Week Price Change | -40.48% |
| 50-Day Moving Average | 64.07 |
| 200-Day Moving Average | 72.29 |
Over the twelve months ended September 30, 2026, Great Tree Pharmacy Co., Ltd. generated 19.30B in revenue and converted that into 484.84M in net income, yielding earnings per share of 2.75. EBITDA reached 1.39B, while operating income came in at 460.34M.
| Revenue | 19.30B |
| Gross Profit | 5.46B |
| Operating Income | 460.34M |
| Pretax Income | 566.37M |
| Net Income | 484.84M |
| EBITDA | 1.39B |
| EBIT | 501.25M |
| Earnings Per Share (EPS) | 2.75 |
As of September 30, 2026, Great Tree Pharmacy Co., Ltd. holds 2.49B in cash and equivalents against 8.09B in total debt, resulting in a net debt position of 2.32B. Total book value stands at 3.79B, with working capital of 2.11B providing operational flexibility.
| Cash & Cash Equivalents | 2.49B |
| Total Debt | 8.09B |
| Net Debt | 2.32B |
| Equity (Book Value) | 3.79B |
| Book Value Per Share | 23.83 |
| Working Capital | 2.11B |
Great Tree Pharmacy Co., Ltd. produced 890.31M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -1.17B in capital expenditures, free cash flow totaled -284.11M - equivalent to -1.79 per share.
| Operating Cash Flow | 890.31M |
| Capital Expenditures | -1.17B |
| Free Cash Flow | -284.11M |
| FCF Per Share | -1.79 |
Over the twelve months ended September 30, 2026, Great Tree Pharmacy Co., Ltd. posted a gross margin of 28.27, reflecting its pricing power and cost economics. The operating margin of 2.38 and net profit margin of 2.51 provide insight into operational efficiency.
| Gross Margin | 28.27 |
| Operating Margin | 2.38 |
| Pretax Margin | 2.93 |
| Profit Margin | 2.51 |
| EBITDA Margin | 7.22 |
Over the twelve months ended September 30, 2026, Great Tree Pharmacy Co., Ltd. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -2.66: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.26, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Great Tree Pharmacy Co., Ltd. shareholders.
| Shareholder Yield | 0.26 |
| FCF Yield | -2.66 |
Great Tree Pharmacy Co., Ltd.'s most recent stock split took place on August 4, 2026 with a 1000:1059 split ratio.
| Last Split Date | 8/4/2026 |
| Split Ratio | 1000:1059 |
As of September 30, 2026, Great Tree Pharmacy Co., Ltd. has an Altman Z-Score of 2.20, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.20 |
Already premium?